New Times,
New Thinking.

  1. Business
  2. Economics
5 December 2013updated 26 Sep 2015 10:16am

Strong US growth robs Osborne of his favourite boast

Minutes after the Chancellor declared that the UK was growing "faster even than America", US growth was revised up.

By George Eaton

One of George Osborne’s favourite new boasts is that the UK is growing faster than any other G7 country. In the most recent quarter, output rose by 0.8%, compared to 0.7% in the US, 0.3% in Germany and 0.4% in Japan. Osborne said in his Autumn Statement: 

I can report that Britain is currently growing faster than any other major advanced economy.

Faster than France, which is contracting.

Faster than Germany, faster even than America.

Unfortunately for the Tories, who were keen to push this line today, that’s no longer true. Just 25 minutes after Osborne sat down, the US published revised growth figures showing that GDP rose by 0.9% in the third quarter, 0.1% above the UK’s growth rate. And, of course, while the UK is still making up lost ground from the recession (the economy is 2.5% smaller than in 2007), the US economy is more than 5% above its previous peak. 

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

But while the US’s sterling performance has robbed Osborne of a political line, a strong American economy is unambiguously good news for the UK and the world. 

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines